|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/22 | (2006.01) |
| A61K 47/68 | (2017.01) | ||
| C07K 16/24 | (2006.01) | ||
| A61P 37/02 | (2006.01) | ||
| A61P 37/06 | (2006.01) |
| (11) | Patento numeris | 3628686 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19208570.2 |
| Europos patento paraiškos padavimo data | 2009-06-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-04-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-07-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 75697 P | 2008-06-25 | US | |
| 7569208 P | 2008-06-25 | US | |
| 155041 P | 2009-02-24 | US | |
| 15510509 P | 2009-02-24 | US | |
| 8322009 | 2009-06-02 | CH |
| (72) |
BORRAS, Leonardo , CH
URECH, David , CH
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | HUMANIZATION OF RABBIT ANTIBODIES USING A UNIVERSAL ANTIBODY FRAMEWORK |
| HUMANIZATION OF RABBIT ANTIBODIES USING A UNIVERSAL ANTIBODY FRAMEWORK |